Dr. Jeromy T. Hackney, MD

Dr. Hackney practices at Texas Oncology PA in Webster, Texas.

Dr. Hackney's NPI, 1225263817, was assigned on May 26, 2009. Dr. Hackney graduated from Joe R. & Teresa Lozano Long School of Medicine in 2009. Dr. Hackney holds Texas license P9582.

Dr. Hackney's primary practice is Texas Oncology PA, at 400 Medical Center Blvd, Webster, TX 77598 in Harris County. The practice phone is (972) 997-8000.

Dr. Hackney's primary practice is Texas Oncology PA in Webster, Texas. Dr. Hackney is also affiliated with HCA Houston Healthcare Clear Lake. The medical group on file is Texas Oncology. Dmand AI also links Dr. Hackney to 2 more hospitals, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hackney practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Hackney's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Hackney is board certified in urology by the American Board of Urology. Dmand AI has Dr. Hackney's licenses on file in 2 states: Texas and Indiana.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Hackney treats.

CMS data shows 1,489 Medicare services from Dr. Hackney across 19 procedure codes in 2024, for 503 Medicare patients. Medicare paid $192,188 for them.

CMS counts 503 Medicare patients who saw Dr. Hackney in 2024. The largest group is 65 to 74, with 227 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hackney's median patient age at 69, with 28% women.

In 2024, Dr. Hackney wrote 1,787 Medicare Part D claims for 536 patients. 89% of them were for generic drugs. CMS names the drug for 1,620 of them, across 25 drugs with 11 or more claims each, at $144,401 in total drug cost. In 2023, CMS named 1,233 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Hackney for performance year 2024, reported through an alternative payment model (APM). Dr. Hackney accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hackney as offering telehealth. CMS counts 23 procedures of prostate resection by Dr. Hackney, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Hackney in 2013. Dr. Hackney's most frequent co-authors are Richard Bihrle, MD, Paul Thomas Gellhaus, MD and Michael G. House, MD.

CMS Open Payments shows 397 general payments to Dr. Hackney from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Boston Scientific Corporation paid the most, $1,717.

Dr. Hackney graduated from Joe R. & Teresa Lozano Long School of Medicine in 2009.

Dr. Hackney is in network with 22 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.